Malaysia Conditionally Approves Ronapreve for Covid Treatment

Anisah Shukry

Link to statement

Malaysia

Coronavirus

Regulation

Switzerland

Great Britain

Government

Europe

Industrials

Healthcare

Emerging Markets

Asia

United Kingdom

Science

Front-line Services at Kuala Lumpur Hospital As Southeast Asia's Deadly Covid Wave Looks to Have Peaked

Malaysia’s Drug Control Authority has granted conditional registration for Ronapreve Solution for Injection or Infusion, according to Health Director-General Noor Hisham Abdullah in a statement.

Bloomberg subscribers can save articles and view them from any device.

Upgrade to an unlimited subscription to save articles and view them from anywhere.

Bloomberg subscribers can send up to {count} articles a month to anyone to read for free, including non-subscribers.

Upgrade your subscription to send up to {count} articles a month to anyone to read for free, including non-subscribers.

Copy article link

Hello,<p>A Bloomberg.com subscriber thought you might want to read this story. To read it, all you need to do is click on the link – no subscription necessary. (Please note the link will only be valid for {days} days.)

Email article link

Please try again. If the problem persists, please contact customer support.

Something went wrong

We've doubled your gift articles this month. Share up to {count} articles with friends, family or colleagues.

As a subscriber, you can gift up to {count} articles this month. The recipient can read the full article for free – no subscription necessary.

As a subscriber, you can gift up to {count} articles each month. The recipient can read the full article for free – no subscription necessary.